Some aspects of interindividual variations in the metabolism of xenobiotics

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Differences in drug metabolism among individuals are caused by numerous factors: differences in production and stability of mRNA of xenobiotic metabolizing enzymes, differences in the rate of enzyme synthesis and degradation, or enzyme inhibition. One of the most important reasons is genetic polymorphism of cytochrome P450 genes or cytochrome P450 regulatory factors. Nuclear receptors play great role in the regulation of these genes. The presence of the ligand induces the nuclear receptor to bind to the dimerisation partner and as a hetero/homodimer it can activate the DNA responsive element. In addition, several co-activators, co-repressors and other factors can modulate the effect of nuclear receptors. Hepatic levels of cytochrome P450 enzymes are reduced in multiple models of inflammation or infection. Cytochrome P450 enzymes of four families (CYP1-CYP4) are known to be involved in xenobiotic metabolism. Their genetic polymorphism and regulation are discussed in this review.

Original languageEnglish
Pages (from-to)322-333
Number of pages12
JournalInflammation Research
Volume52
Issue number8
DOIs
Publication statusPublished - Aug 1 2003

Fingerprint

Xenobiotics
Metabolism
Cytochrome P-450 Enzyme System
Cytoplasmic and Nuclear Receptors
Genetic Polymorphisms
Polymorphism
Enzymes
Genes
Enzyme inhibition
Co-Repressor Proteins
Dimerization
RNA Stability
Ligands
Inflammation
Degradation
Messenger RNA
Liver
DNA
Infection
Pharmaceutical Preparations

Keywords

  • Cytochrome P450 gene
  • Inducers
  • Nuclear receptors
  • Polymorphism
  • Regulation

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology (medical)
  • Immunology
  • Cell Biology

Cite this

Some aspects of interindividual variations in the metabolism of xenobiotics. / Tamási, V.; Vereczkey, L.; Falus, A.; Monostory, K.

In: Inflammation Research, Vol. 52, No. 8, 01.08.2003, p. 322-333.

Research output: Contribution to journalArticle

@article{680426a5bdf94d37b7684fcbd4c04ab1,
title = "Some aspects of interindividual variations in the metabolism of xenobiotics",
abstract = "Differences in drug metabolism among individuals are caused by numerous factors: differences in production and stability of mRNA of xenobiotic metabolizing enzymes, differences in the rate of enzyme synthesis and degradation, or enzyme inhibition. One of the most important reasons is genetic polymorphism of cytochrome P450 genes or cytochrome P450 regulatory factors. Nuclear receptors play great role in the regulation of these genes. The presence of the ligand induces the nuclear receptor to bind to the dimerisation partner and as a hetero/homodimer it can activate the DNA responsive element. In addition, several co-activators, co-repressors and other factors can modulate the effect of nuclear receptors. Hepatic levels of cytochrome P450 enzymes are reduced in multiple models of inflammation or infection. Cytochrome P450 enzymes of four families (CYP1-CYP4) are known to be involved in xenobiotic metabolism. Their genetic polymorphism and regulation are discussed in this review.",
keywords = "Cytochrome P450 gene, Inducers, Nuclear receptors, Polymorphism, Regulation",
author = "V. Tam{\'a}si and L. Vereczkey and A. Falus and K. Monostory",
year = "2003",
month = "8",
day = "1",
doi = "10.1007/s00011-003-1186-4",
language = "English",
volume = "52",
pages = "322--333",
journal = "Inflammation Research",
issn = "1023-3830",
publisher = "Birkhauser Verlag Basel",
number = "8",

}

TY - JOUR

T1 - Some aspects of interindividual variations in the metabolism of xenobiotics

AU - Tamási, V.

AU - Vereczkey, L.

AU - Falus, A.

AU - Monostory, K.

PY - 2003/8/1

Y1 - 2003/8/1

N2 - Differences in drug metabolism among individuals are caused by numerous factors: differences in production and stability of mRNA of xenobiotic metabolizing enzymes, differences in the rate of enzyme synthesis and degradation, or enzyme inhibition. One of the most important reasons is genetic polymorphism of cytochrome P450 genes or cytochrome P450 regulatory factors. Nuclear receptors play great role in the regulation of these genes. The presence of the ligand induces the nuclear receptor to bind to the dimerisation partner and as a hetero/homodimer it can activate the DNA responsive element. In addition, several co-activators, co-repressors and other factors can modulate the effect of nuclear receptors. Hepatic levels of cytochrome P450 enzymes are reduced in multiple models of inflammation or infection. Cytochrome P450 enzymes of four families (CYP1-CYP4) are known to be involved in xenobiotic metabolism. Their genetic polymorphism and regulation are discussed in this review.

AB - Differences in drug metabolism among individuals are caused by numerous factors: differences in production and stability of mRNA of xenobiotic metabolizing enzymes, differences in the rate of enzyme synthesis and degradation, or enzyme inhibition. One of the most important reasons is genetic polymorphism of cytochrome P450 genes or cytochrome P450 regulatory factors. Nuclear receptors play great role in the regulation of these genes. The presence of the ligand induces the nuclear receptor to bind to the dimerisation partner and as a hetero/homodimer it can activate the DNA responsive element. In addition, several co-activators, co-repressors and other factors can modulate the effect of nuclear receptors. Hepatic levels of cytochrome P450 enzymes are reduced in multiple models of inflammation or infection. Cytochrome P450 enzymes of four families (CYP1-CYP4) are known to be involved in xenobiotic metabolism. Their genetic polymorphism and regulation are discussed in this review.

KW - Cytochrome P450 gene

KW - Inducers

KW - Nuclear receptors

KW - Polymorphism

KW - Regulation

UR - http://www.scopus.com/inward/record.url?scp=0041662013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041662013&partnerID=8YFLogxK

U2 - 10.1007/s00011-003-1186-4

DO - 10.1007/s00011-003-1186-4

M3 - Article

C2 - 14504670

AN - SCOPUS:0041662013

VL - 52

SP - 322

EP - 333

JO - Inflammation Research

JF - Inflammation Research

SN - 1023-3830

IS - 8

ER -